or
Bookmark and Share
Hydrophilic copolymers based on N-[tris(hydroxymethyl)methyl]-acrylamide, processes for their preparation, aqueous gels of said copolymers and their use as ion exchangers
   
Document Number
US Patent 4452916
Issued Date
June 5, 1984
Link
Inventors
Map
Abstract
Tridimensional cross-linked random copolymers, insoluble in water, containing in copolymerized form: (a) 25% to 98% by weight of N-[tris(hydroxymethyl)methyl]acrylamide or N-[tris(hydroxymethyl)methyl]methacrylamide, or a mixture of these two compounds. (b) 2% to 50% by weight of one or more monomers containing two or several polymerizable ethylenic double bonds and free from anionic or cationic functional groups, and (c) 0.1% to 50% by weight of one or more monomers containing a polymerizable ethylenic double bond and one or more mono- or di-substituted amino, pyrimidinyl, guanidyl, purinyl, quaternary ammonium, SO.sub.3 H or SO.sub.3 M groups, M being an alkali metal. These copolymers are utilizable, in the form of aqueous gels, as ion exchangers.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
12
Comments:
no comments yet
Owner
Pharmindustrie (Gennevilliers,FR)
Published
June 5, 1984
Application Number
06/415,961
Filed
September 8, 1982
US Classification
521/38   526/258 526/259 526/285 526/287 526/288 526/304
Int'l Classification
C08F   220/58   (20060101)   C08F   220/00   (20060101)  
Assistant Examiner
Attorney/Law Firm
Parent Case
This is a continuation of application Ser. No. 258,130, filed Apr. 27, 1981, and now abandoned.
Priority Data
May 09, 1980 [FR] 80 10382
USPTO Field of Search
521/38   526/310   526/304  
Related Patents
5319046 - Polymers, and their use as gels for electrophoresis - Owned by Elchrom, Ltd. (Horgen,CH)

A novel synthesis of N-acryloyl-tris-(hydroxymethyl)aminomethane (NAT) is described. The polymerization kinetics and transparency of the poly(NAT) gels crosslinked by a crosslinker (CL) e.g. N,N'-methylenebisacrylamide (Bis), i.e. poly(NAT+Bis) polymer, are shown. Poly(NAT+Bis) gradient (4-24%) gels were prepared and found to resolve native proteins according to their size. The exclusion limit of these gels is over 3.times.10.sup.6 Da. This is more than threefold higher than the exclusion limit of the polyacrylamide gradient gel of the same concentration. Therefore poly(NAT+CL) gels are better than polyacrylamide gels for the resolution of large proteins. It was demonstrated that poly(NAT+CL)-polyacrylamide composite gels could be prepared. The poly(NAT+CL) gels were found to be advantageous also for isoelectric focussing in carrier ampholytes or immobilized pH gradients. Poly(NAT+CL) gels are also very good for separation of nucleic acids. The resolution is particularly good in the range between several hundred to 4-5000 base pairs. Under the optimized conditions, DNA molecules of more than 20 kbases can be perfectly resolved.

4610305 - Oilfield flooding polymer - Owned by The New Mexico Institute of Mining and Technology (Socorro, NM)

A monomer, polymers containing the monomer, and the use of the polymer in oilfield flooding is disclosed. The subject monomer is represented by the general formula: ##STR1## wherein: n is an integer from 0 to about 4; m is an integer from 0 to about 6; a is an integer equal to at least 1 except where m is equal to 0, a must equal 0 and where m is equal to 1, a must equal 0 or 1; p is an integer from 2 to about 10; b is an integer equal to at least 1 and is of sufficient magnitude that the ratio b/p is at least 0.2; and q is an integer from 0 to 2. The number of hydroxy groups in the monomer is believed to be critical, and therefore the sum of (a+b) divided by the sum (m+p) should be at least 0.2. The moieties linked to the acrylic nitrogen can be joined to provide a ringed structure.

6436424 - Injectable and swellable microspheres for dermal augmentation - Owned by Biosphere Medical, Inc. (Rockland, MA)

The present invention relates to injectable compositions comprising biocompatible, swellable, hydrophilic, non-toxic and substantially spherical microspheres microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further relates to methods of dermal augmentation, particularly for the treatment of skin contour deficiencies, using the injectable compositions.

6335028 - Implantable particles for urinary incontinence - Owned by Biosphere Medical, Inc. (Rockland, MA)

The invention encompasses the treatment of urinary incontinence, gastroesophageal reflux disease and the amelioration of skin wrinkles using biocompatible hydrophilic cationic microparticles and a cell adhesion promoter.

6660301 - Injectable microspheres for dermal augmentation and tissue bulking - Owned by Biosphere Medical, Inc. (Rockland, MA)

The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions comprising the microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further provides methods of dermal augmentation and tissue bulking, particularly for the treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us